ID   Kasumi-10
AC   CVCL_8485
SY   KASUMI-10
DR   GEO; GSM4254138
DR   GEO; GSM5137757
DR   JCRB; JCRB1410
DR   PRIDE; PXD023662
DR   Wikidata; Q54899515
RX   PubMed=32180206;
RX   PubMed=35354797;
CC   Population: Japanese and Korean.
CC   Karyotypic information: While originating from a female patient, it has a XXY karyotype that could be explained by a disorder of sexual development (PubMed=32180206).
CC   Sequence variation: Gene fusion; HGNC; 7132; KMT2A + HGNC; 7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1; MLL-ENL (PubMed=32180206; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; 3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=32180206).
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
ST   Source(s): JCRB=JCRB1410; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 12,15
ST   D12S391: 18,22
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 15.2,16
ST   D1S1656: 15,17
ST   D21S11: 30
ST   D22S1045: 15,17
ST   D2S1338: 19,24
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   DYS391: 9
ST   FGA: 22,27.2
ST   SE33: 20,26.2
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 17,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 20
//
RX   PubMed=32180206; DOI=10.1007/s13577-020-00347-5; PMCID=PMC7324421;
RA   Kasai F., Asou H., Ozawa M., Kobayashi K., Kuramitsu H., Satoh M.,
RA   Kohara A., Kaneko Y., Kawamura M.;
RT   "Kasumi leukemia cell lines: characterization of tumor genomes with
RT   ethnic origin and scales of genomic alterations.";
RL   Hum. Cell 33:868-876(2020).
//
RX   PubMed=35354797; DOI=10.1038/s41467-022-29224-5; PMCID=PMC8967900;
RA   Leo I.R., Aswad L., Stahl M., Kunold E., Post F., Erkers T.,
RA   Struyf N., Mermelekas G., Joshi R.N., Gracia-Villacampa E.,
RA   Ostling P., Kallioniemi O.-P., Pokrovskaja Tamm K., Siavelis I.,
RA   Lehtio J., Vesterlund M., Jafari R.;
RT   "Integrative multi-omics and drug response profiling of childhood
RT   acute lymphoblastic leukemia cell lines.";
RL   Nat. Commun. 13:1691.1-1691.19(2022).
//